<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04055558</url>
  </required_header>
  <id_info>
    <org_study_id>RMC-0109-17</org_study_id>
    <nct_id>NCT04055558</nct_id>
  </id_info>
  <brief_title>Lymphoproliferative Disorders After Diagnosis of Childhood Acute Lymphoblastic Leukemia/Lymphoma</brief_title>
  <official_title>Lymphoproliferative Disorders After Diagnosis of Childhood Acute Lymphoblastic Leukemia/Lymphoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rabin Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Israeli Society for Pediatric Hematology-Oncology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>International BFM Study Group</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Rabin Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Lymphoproliferative disorders (LPD) are a major cause of morbidity and mortality in
      immunodeficient patients. There have been isolated case reports of patients with childhood
      ALL who developed LPD after ALL diagnosis, without undergoing stem cell transplantation, but
      data regarding such cases are limited. We propose here an international collaboration, to
      form a comprehensive database of children who developed LPD after diagnosis of acute
      lymphoblastic leukemia/lymphoma
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Lymphoproliferative disorders (LPD) are a major cause of morbidity and mortality in
      immunodeficient patients. These disorders have been extensively described in the
      post-transplant setting, ie after hematopoietic stem cell (SCT) or solid organ (SOT)
      transplant. However, since the 1980's, there have been isolated case reports of patients with
      childhood ALL, who developed LPD after diagnosis of ALL, without undergoing SCT.
      Comprehensive information is unavailable regarding the prevalence, clinical manifestations,
      treatment, outcome and pathogenesis of such disorders in this setting. We propose here an
      international collaboration, to form a comprehensive database of children who developed LPD
      during the treatment of acute lymphoblastic leukemia/lymphoma (ALL/LBL).

      Information will be collected in a de-identified fashion regarding patient characteristics,
      leukemia and LPD characteristics, treatment and outcome. The aims of this retrospective study
      are:

        1. To build a database of children who developed LPD after diagnosis of ALL/LBL

        2. To investigate the characteristics and outcome of this disorder
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 25, 2019</start_date>
  <completion_date type="Anticipated">March 18, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 18, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Probability of survival</measure>
    <time_frame>1 year</time_frame>
    <description>Assess six-month probability of survival since LPD diagnosis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Event-free survival</measure>
    <time_frame>5 years</time_frame>
    <description>Assess 5-year event-free survival since acute lymphoblastic leukemia/lymphoma diagnosis</description>
  </secondary_outcome>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Childhood Leukemia and Lymphoma</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Children and young adults (&lt;30 years of age), previously diagnosed with acute lymphoblastic
        leukemia/lymphoma, who developed LPD after ALL/LBL diagnosis
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Children and young adults treated for acute lymphoblasticleukemia/lymphoma who
             developed LPD after ALL/LBL diagnosis

        Exclusion Criteria:

          -  age&gt;30 years
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sarah Elitzur, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Schneider Children's Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sarah Elitzur, MD</last_name>
    <phone>97239253669</phone>
    <email>sarhae@clalit.org.il</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Naomi Litichever, PhD</last_name>
    <phone>97239253669</phone>
    <email>naomilitichever@clalit.org.il</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Schneider Children's Medical Center</name>
      <address>
        <city>Petah Tikva</city>
        <zip>4920235</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Elitzur, MD</last_name>
      <phone>97239253669</phone>
      <email>sarhae@clalit.org.il</email>
    </contact>
    <contact_backup>
      <last_name>Naomi Litichever, PhD</last_name>
      <phone>97239253669</phone>
      <email>naomilitichever@clalit.org.il</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Schneider Children's Medical Center</name>
      <address>
        <city>Petah Tikva</city>
        <zip>4920235</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Elitzur, MD</last_name>
      <email>sarhae@clalit.org.il</email>
    </contact>
    <contact_backup>
      <last_name>Naomi Litichever, PhD</last_name>
      <email>naomilitichever@clalit.org.il</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>August 11, 2019</study_first_submitted>
  <study_first_submitted_qc>August 11, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 13, 2019</study_first_posted>
  <last_update_submitted>July 19, 2020</last_update_submitted>
  <last_update_submitted_qc>July 19, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>childhood leukemia</keyword>
  <keyword>lymphoproliferative disorders</keyword>
  <keyword>EBV</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lymphoma</mesh_term>
    <mesh_term>Leukemia</mesh_term>
    <mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
    <mesh_term>Leukemia, Lymphoid</mesh_term>
    <mesh_term>Lymphoproliferative Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

